ERD

Periodic Reporting for period 2 - I-DireCT (Immune DIREcted and Cancer-selective immunoTherapy)

Project: I-DireCT

Updated at: 03-09-2024

Show more information

Project acronym I-DireCT

I-DireCT summer school

Project: I-DireCT

Updated at: 15-06-2024

Show more information

Project acronym I-DireCT

Press event

Project: I-DireCT

Updated at: 15-06-2024

Show more information

Project acronym I-DireCT

Advancing Cancer Immunotherapy with Nanomedicine

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Identification and pre-clinical validation of tumour-targeted checkpoint drugs

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Update 1 online knowledge bases

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening ...

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate w...

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T ce...

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Using Nanomedicine to Drive Advances in Cancer Immunotherapy: A Mini Review.

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Update 3 online knowledge bases

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity.

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Update 4 online knowledge bases

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Update 2 online knowledge bases

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Frontiers in Immunology EBook

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

List of PhDs theses

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Whispering Gallery Modes-based biosensors for real-time monitoring and binding characterization of antibody-based cancer...

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Characterization of new tumour-selective TNFR family-targeted drugs

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Development of vaterite particles for therapeutic protein drug delivery and pH-sensitive release mimicking the tumor mic...

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Report on kick-off meeting

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Presentations at Antibody engineering workshops 2

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Presentations at Antibody engineering workshops

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Si...

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Galectin-9 has non-apoptotic cytotoxic activity towards Acute Myeloid Leukemia independent of cytarabine resistance.

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Facing the Challenges of Pharmaceutical Research Using Whispering Gallery Modes-Based Biosensors

Project: I-DireCT

Updated at: 28-04-2024

Show more information

Project acronym I-DireCT

Resources

Selected filters:

Periodic Reporting for period 2 - I-DireCT (Immune DIREcted and Cancer-selective immunoTherapy)

I-DireCT summer school

Press event

Advancing Cancer Immunotherapy with Nanomedicine

Identification and pre-clinical validation of tumour-targeted checkpoint drugs

Update 1 online knowledge bases

A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening ...

Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate w...

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T ce...

Using Nanomedicine to Drive Advances in Cancer Immunotherapy: A Mini Review.

Update 3 online knowledge bases

The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer

Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity

Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity.

Update 4 online knowledge bases

Update 2 online knowledge bases

Frontiers in Immunology EBook

List of PhDs theses

Whispering Gallery Modes-based biosensors for real-time monitoring and binding characterization of antibody-based cancer...

Characterization of new tumour-selective TNFR family-targeted drugs

Development of vaterite particles for therapeutic protein drug delivery and pH-sensitive release mimicking the tumor mic...

Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily

Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment

Report on kick-off meeting

Presentations at Antibody engineering workshops 2

Presentations at Antibody engineering workshops

Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist

The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Si...

Galectin-9 has non-apoptotic cytotoxic activity towards Acute Myeloid Leukemia independent of cytarabine resistance.

Facing the Challenges of Pharmaceutical Research Using Whispering Gallery Modes-Based Biosensors